DXP ENTERPRISES INC
For the period ended Sep 30, 2025. Filed Nov 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 6, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
ITEM 1. Financial Statements
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
AND COMPREHENSIVE INCOME
(in thousands, except per share amounts) (unaudited)
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Sales | $513,724 | $472,935 | $1,488,975 | $1,331,126 |
| Cost of sales | 352,465 | 326,825 | 1,019,638 | 923,341 |
| Gross profit | 161,259 | 146,110 | 469,337 | 407,785 |
| Selling, general and administrative expenses | 117,561 | 106,502 | 339,138 | 301,694 |
| Income from operations | 43,698 | 39,608 | 130,199 | 106,091 |
| Interest expense | 14,894 | 15,716 | 44,298 | 46,644 |
| Other (income) expense, net (Note 15) | (648) | 160 | (2,320) | (2,844) |
| Income before income taxes | 29,452 | 23,732 | 88,221 | 62,291 |
| Provision for income taxes | 7,821 | 2,631 | 22,389 | 13,165 |
| Net income | 21,631 | 21,101 | 65,832 | 49,126 |
| Preferred stock dividend | 23 | 23 | 68 | 68 |
| Net income attributable to common shareholders | $21,608 | $21,078 | $65,764 | $49,058 |
| Net income | $21,631 | $21,101 | $65,832 | $49,126 |
| Foreign currency translation adjustments | (709) | 380 | 1,940 | (141) |
| Comprehensive income | $20,922 | $21,481 | $67,772 | $48,985 |
| Earnings per share (Note 9): | ||||
| Basic | $1.38 | $1.34 | $4.19 | $3.08 |
| Diluted | $1.31 | $1.27 | $3.98 | $2.93 |
| Weighted average common shares outstanding: | ||||
| Basic | 15,686 | 15,750 | 15,693 | 15,915 |
| Diluted | 16,526 | 16,590 | 16,533 | 16,755 |
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except share amounts) (unaudited)
| September 30, 2025 | December 31, 2024 | |
|---|---|---|
| ASSETS | ||
| Current assets: | ||
| Cash | $123,829 | $148,320 |
| Restricted cash | — | 91 |
| Accounts receivable, net of allowance of $4,175 and $5,172, respectively | 379,328 | 339,365 |
| Inventories | 109,055 | 103,113 |
| Costs and estimated profits in excess of billings | 57,696 | 50,735 |
| Prepaid expenses and other current assets | 57,020 | 20,250 |
| Total current assets | 726,928 | 661,874 |
| Property and equipment, net | 110,957 | 81,556 |
| Goodwill | 466,710 | 452,343 |
| Other intangible assets, net | 75,419 | 85,679 |
| Operating lease right of use assets, net | 59,936 | 46,569 |
| Other long-term assets | 4,504 | 21,473 |
| Total assets | $1,444,454 | $1,349,494 |
| LIABILITIES AND EQUITY | ||
| Current liabilities: | ||
| Current maturities of debt | $6,595 | $6,595 |
| Trade accounts payable | 115,216 | 103,728 |
| Accrued wages and benefits | 47,693 | 41,650 |
| Customer advances | 15,864 | 13,655 |
| Billings in excess of costs and estimated profits | 17,060 | 12,662 |
| Short-term operating lease liabilities | 17,163 | 14,921 |
| Other current liabilities | 42,697 | 50,773 |
| Total current liabilities | 262,288 | 243,984 |
| Long-term debt, net of unamortized debt issuance costs and discounts | 619,396 | 621,684 |
| Long-term operating lease liabilities | 44,535 | 33,159 |
| Other long-term liabilities | 29,896 | 27,879 |
| Total long-term liabilities | 693,827 | 682,722 |
| Total liabilities | 956,115 | 926,706 |
| Commitments and Contingencies (Note 10) | ||
| Shareholders' equity: | ||
| Series A preferred stock, $1.00 par value; 1,000,000 shares authorized | 1 | 1 |
| Series B preferred stock, $1.00 par value; 1,000,000 shares authorized | 15 | 15 |
| Common stock, $0.01 par value, 100,000,000 shares authorized; 20,404,367 issued and 15,677,406 outstanding at September 30, 2025 and 20,402,861 issued and 15,695,088 outstanding at December 31, 2024 | 204 | 204 |
| Additional paid-in capital | 219,329 | 219,511 |
| Retained earnings | 455,434 | 389,670 |
| Accumulated other comprehensive loss | (31,670) | (33,610) |
| Treasury stock, at cost 4,726,961 and 4,707,773 shares, respectively | (154,974) | (153,003) |
| Total DXP Enterprises, Inc. equity | 488,339 | 422,788 |
| Total liabilities and equity | $1,444,454 | $1,349,494 |
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands) (unaudited)
| Nine Months Ended September 30, | ||
|---|---|---|
| 2025 | 2024 | |
| CASH FLOWS FROM OPERATING ACTIVITIES: | ||
| Net income | $65,832 | $49,126 |
| Reconciliation of net income to net cash provided by operating activities: | ||
| Depreciation | 7,646 | 6,821 |
| Amortization of intangibles and finance lease assets | 20,898 | 17,564 |
| Amortization of debt issuance costs | 2,908 | 2,678 |
| Gain on sale of property and equipment | (426) | — |
| Recovery of (provision for) credit losses | 74 | (783) |
| Payment of contingent consideration liability in excess of acquisition-date fair value | (459) | (108) |
| Fair value adjustment on contingent consideration | 932 | 380 |
| Restricted stock compensation expense | 4,278 | 3,398 |
| Deferred income taxes | 23,503 | (10,376) |
| Other non-cash items | (8,142) | 152 |
| Changes in operating assets and liabilities, net of effects of businesses acquired: | ||
| Accounts receivable | (33,346) | (12,325) |
| Costs and estimated profits in excess of billings | (6,914) | (7,392) |
| Inventories | (1,332) | 1,130 |
| Prepaid expenses and other assets | (9,867) | 772 |
| Trade accounts payable | 6,766 | 1,323 |
| Accrued expenses | 16,947 | 11,894 |
| Billings in excess of costs and estimated profits | 3,989 | 2,410 |
| Income taxes | (36,782) | 3,404 |
| Net cash provided by operating activities | $56,505 | $70,068 |
| CASH FLOWS FROM INVESTING ACTIVITIES: | ||
| Purchase of property and equipment | (37,000) | (15,673) |
| Proceeds from the sale of property and equipment | 2,715 | — |
| Acquisition of businesses, net of cash acquired | (24,448) | (149,440) |
| Net cash used in investing activities | $(58,733) | $(165,113) |
| CASH FLOWS FROM FINANCING ACTIVITIES: | ||
| Borrowings on asset-backed credit facility | — | 6,000 |
| Repayments on asset-backed credit facility | — | (6,000) |
| Principal debt payments | (4,871) | (4,125) |
| Debt issuance costs | (325) | — |
| Shares repurchased held in treasury | (1,999) | (28,783) |
| Payment for acquisition contingent consideration liability | (6,874) | (4,580) |
| Preferred stock dividends paid | (68) | (68) |
| Payment for employee taxes withheld from stock awards | (4,460) | (1,818) |
| Principal payments on finance leases | (4,597) | (3,010) |
| Net cash used in financing activities | $(23,194) | $(42,384) |
| Effect of foreign currency on cash | 840 | (691) |
| Net change in cash and restricted cash | (24,582) | (138,120) |
| Cash and restricted cash at beginning of period | 148,411 | 173,211 |
| Cash and restricted cash at end of period | $123,829 | $35,091 |
| Supplemental cash flow information (Note 14) | ||
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY
(in thousands) (unaudited)
| Series A preferred stock | Series B preferred stock | Common stock | Paid-in capital | Retained earnings | Accum other comp loss | Treasury Stock | Total equity | |
|---|---|---|---|---|---|---|---|---|
| Balance at December 31, 2024 | $1 | $15 | $204 | $219,511 | $389,670 | $(33,610) | $(153,003) | $422,788 |
| Preferred dividends paid | — | — | — | — | (23) | — | — | (23) |
| Compensation expense for restricted stock | — | — | — | 1,317 | — | — | — | 1,317 |
| Tax related items for share based awards | — | — | — | (126) | — | — | — | (126) |
| Currency translation adjustment | — | — | — | — | — | 86 | — | 86 |
| Excise tax on share repurchases | — | — | — | — | — | — | 28 | 28 |
| Net income | — | — | — | — | 20,589 | — | — | 20,589 |
| Balance at March 31, 2025 | $1 | $15 | $204 | $220,702 | $410,236 | $(33,524) | $(152,975) | $444,659 |
| Preferred dividends paid | — | — | — | — | (22) | — | — | (22) |
| Compensation expense for restricted stock | — | — | — | 1,483 | — | — | — | 1,483 |
| Tax related items for share based awards | — | — | — | (4,203) | — | — | — | (4,203) |
| Currency translation adjustment | — | — | — | — | — | 2,563 | — | 2,563 |
| Net income | — | — | — | — | 23,612 | — | — | 23,612 |
| Balance at June 30, 2025 | $1 | $15 | $204 | $217,982 | $433,826 | $(30,961) | $(152,975) | $468,092 |
| Preferred dividends paid | — | — | — | — | (23) | — | — | (23) |
| Compensation expense for restricted stock | — | — | — | 1,478 | — | — | — | 1,478 |
| Tax related items for share based awards | — | — | — | (131) | — | — | — | (131) |
| Currency translation adjustment | — | — | — | — | — | (709) | — | (709) |
| Repurchases of shares | — | — | — | — | — | — | (1,999) | (1,999) |
| Net income | — | — | — | — | 21,631 | — | — | 21,631 |
| Balance at September 30, 2025 | $1 | $15 | $204 | $219,329 | $455,434 | $(31,670) | $(154,974) | $488,339 |
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements
| Series A preferred stock | Series B preferred stock | Common stock | Paid-in capital | Retained earnings | Accum other comp loss | Treasury Stock | Total equity | |
|---|---|---|---|---|---|---|---|---|
| Balance at December 31, 2023 | $1 | $15 | $345 | $216,482 | $319,271 | $(31,240) | $(123,995) | $380,879 |
| Preferred dividends paid | — | — | — | — | (23) | — | — | (23) |
| Compensation expense for restricted stock | — | — | — | 864 | — | — | — | 864 |
| Tax related items for share based awards | — | — | — | (54) | — | — | — | (54) |
| Currency translation adjustment | — | — | — | — | — | (614) | — | (614) |
| Repurchases of shares | — | — | — | — | — | — | (16,805) | (16,805) |
| Excise tax on share repurchases | — | — | — | — | — | — | (115) | (115) |
| Net income | — | — | — | — | 11,332 | — | — | 11,332 |
| Balance at March 31, 2024 | $1 | $15 | $345 | $217,292 | $330,580 | $(31,854) | $(140,915) | $375,464 |
| Preferred dividends paid | — | — | — | — | (22) | — | — | (22) |
| Compensation expense for restricted stock | — | — | — | 1,212 | — | — | — | 1,212 |
| Tax related items for share based awards | — | — | — | (1,701) | — | — | — | (1,701) |
| Currency translation adjustment | — | — | — | — | — | 93 | — | 93 |
| Repurchases of shares | — | — | — | — | — | — | (6,992) | (6,992) |
| Excise tax on share repurchases | — | — | — | — | — | — | (66) | (66) |
| Net income | — | — | — | — | 16,693 | — | — | 16,693 |
| Balance at June 30, 2024 | $1 | $15 | $345 | $216,803 | $347,251 | $(31,761) | $(147,973) | $384,681 |
| Preferred dividends paid | — | — | — | — | (23) | — | — | (23) |
| Restricted stock compensation expense | — | — | — | 1,322 | — | — | — | 1,322 |
| Tax related items for share based awards | — | — | — | (63) | — | — | — | (63) |
| Currency translation adjustment | — | — | — | — | — | 380 | — | 380 |
| Repurchases of shares | — | — | — | — | — | — | (4,985) | (4,985) |
| Excise tax on share repurchases | — | — | — | — | — | — | (45) | (45) |
| Net income | — | — | — | — | 21,101 | — | — | 21,101 |
| Balance at September 30, 2024 | $1 | $15 | $345 | $218,062 | $368,329 | $(31,381) | $(153,003) | $402,368 |
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1 -THE COMPANY
DXP Enterprises, Inc. together with its subsidiaries (collectively "DXP," the "Company," "us," "we," or "our") was incorporated in Texas on July 26, 1996. DXP Enterprises, Inc. and its subsidiaries are engaged in the business of distributing maintenance, repair and operating ("MRO") products and services to a variety of end markets and business-to-business customers. Additionally, DXP provides integrated, custom pump skid packages, pump remanufacturing and manufactures branded private label pumps to energy and broad industrial customers. The Company is currently organized into three business segments: Service Centers ("SC"), Innovative Pumping Solutions ("IPS"), and Supply Chain Services ("SCS"). See Note 11 - Segment Reporting for discussion of the business segments.
NOTE 2 -SUMMARY OF SIGNIFICANT ACCOUNTING AND BUSINESS POLICIES
Basis of Presentation
The Company's financial statements are prepared in accordance with generally accepted accounting principles in the United States of America ("U.S. GAAP"). For interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X of the U.S. Securities and Exchange Commission ("SEC") not all disclosures normally required in annual consolidated financial statements prepared in accordance with U.S. GAAP are required. The unaudited condensed consolidated financial statements should be read in conjunction with our audited consolidated financial statements for the year ended December 31, 2024 that are included in our annual report on Form 10-K filed with the SEC on March 10, 2025 (“Annual Report”).
Certain reclassifications were made to the prior year’s consolidated financial statements to conform to the current year presentation. Such reclassifications did not have a material effect on our consolidated statements of operations and comprehensive income, balance sheets, cash flows or equity.
The results of operations for the three and nine months ended September 30, 2025 are not necessarily indicative of results expected for the full fiscal year. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary for the fair statement of the Company's financial position, results of operations and cash flows for the interim periods presented.
All intercompany accounts and transactions have been eliminated in consolidation.
NOTE 3 -RECENT ACCOUNTING PRONOUNCEMENTS
All new accounting pronouncements that have been issued but not yet effective are currently being evaluated and at this time are not expected to have a material impact on our financial position or results of operations.
Accounting Pronouncements Not Yet Adopted
In November 2024, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2024-03, Disaggregation of Income Statement Expenses (Subtopic 220-40). The ASU requires the disaggregated disclosure of specific expense categories, including purchases of inventory, employee compensation, depreciation, and amortization, within relevant income statement captions. This ASU also requires disclosure of the total amount of selling expenses along with the definition of selling expenses. The ASU is effective for annual periods beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. Adoption of this ASU can either be applied prospectively to consolidated financial statements issued for reporting periods after the effective date of this ASU or retrospectively to any or all prior periods presented in the consolidated financial statements. Early adoption is also permitted. This ASU would result in additional disclosures being included in our consolidated financial statements, once adopted. We are currently evaluating the provisions of this ASU.
In December 2023, FASB issued ASU No. 2023-09, Improvements to Income Tax Disclosures (Topic 740). The ASU requires disaggregated information about a reporting entity’s effective tax rate reconciliation as well as additional information on income taxes paid. The ASU is effective on a prospective basis for annual periods beginning after December 15, 2024. Early adoption is also permitted for annual financial statements that have not yet been issued or made available for issuance. This ASU will likely result in the required additional disclosures being included in our consolidated financial statements, once adopted. We are currently evaluating the provisions of this ASU.
NOTE 4 -FAIR VALUE OF FINANCIAL ASSETS AND LIABILITIES
Our acquisitions may include contingent consideration as part of the purchase price. The fair value of the contingent consideration is estimated as of the acquisition date based on the present value of the contingent payments to be made using a weighted probability of possible payments. The unobservable inputs used in the determination of the fair value of the contingent consideration include management's assumptions about the likelihood of payment based on the established benchmarks, discount rates, and an internal rate of return analysis. The fair value measurement includes inputs that are Level 3 inputs as they are not observable in the market. Should actual results increase or decrease as compared to the assumptions used in our analysis, the fair value of the contingent consideration obligations will increase or decrease, up to the contracted limit, as applicable. Changes in the fair value of the contingent consideration are measured each reporting period and reflected in our results of operations.
As of September 30, 2025, there was $10.6 million in other current and other long-term liabilities for contingent consideration.
The following table provides a reconciliation of the beginning and ending balances and gains or losses recognized during the nine months ended September 30, 2025 (in thousands):
| Contingent Consideration | |
|---|---|
| *Beginning balance at December 31, 2024 | $16,322 |
| Acquisitions and settlements: | |
| Acquisitions (Note 12) | 683 |
| Settlements | (7,333) |
| Total remeasurement adjustments: | |
| Changes in fair value recorded in other expense (income), net | 932 |
| *Ending Balance at September 30, 2025 | $10,604 |
| *Amounts included in other current liabilities were $7.7 million and $8.0 million for the periods ending September 30, 2025 and December 31, 2024, respectively. Amounts included in other long-term liabilities were $2.9 million and $8.3 million for the periods ending September 30, 2025 and December 31, 2024, respectively. | |
Sensitivity to Changes in Significant Unobservable Inputs
The significant Level 3 unobservable inputs used in the fair value measurement of contingent consideration related to the acquisitions are annualized EBITDA forecasts developed by the Company's management and the probability of achievement of those EBITDA results. The discount rate used in the calculations was 9.3 percent. Changes in our unobservable inputs in isolation would result in a change to our fair value measurement. As of September 30, 2025, the maximum amount of contingent consideration payable under these arrangements is $11.8 million over three years.
Other financial instruments not measured at fair value on the Company's unaudited condensed consolidated balance sheets at September 30, 2025 and December 31, 2024, but which require disclosure of their fair values include: cash, restricted cash, accounts receivable, trade accounts payable and accrued expenses. The Company believes that the estimated fair value of such instruments at September 30, 2025 and December 31, 2024 approximates their carrying value as reported on the unaudited condensed consolidated balance sheets due to the relative short maturity of these instruments.
See Note 8 - Long-term Debt for fair value disclosures on our asset-backed line of credit and term loan debt under our syndicated credit agreement facilities.
NOTE 5 –INVENTORIES
Inventories are made up of equipment purchased for resale, and materials utilized in the fabrication of industrial and wastewater equipment stated at lower of cost or net realizable value, primarily determined using the weighted average cost method. The Company reviews inventory and records provisions for the difference between cost and net realizable value arising from excess and obsolete items on hand based upon the aging of the inventories, market trends, and continued demand.
The carrying values of inventories are as follows (in thousands):
| September 30, 2025 | December 31, 2024 | |
|---|---|---|
| Finished goods | $94,728 | $89,780 |
| Work in process | 14,327 | 13,333 |
| Inventories | $109,055 | $103,113 |
NOTE 6 –CONTRACT ASSETS AND LIABILITIES
Under our customized pump production and water and wastewater project contracts, amounts are billed as work progresses in accordance with agreed-upon contractual terms, upon various measures of performance, including achievement of certain milestones, completion of specified units, or completion of a contract. Generally, billing occurs subsequent to revenue recognition, resulting in contract assets presented as "Costs and estimated profits in excess of billings." However, we sometimes receive advances or deposits from our customers before revenue is recognized, resulting in contract liabilities that are presented as "Billings in excess of costs and estimated profits" on our unaudited condensed consolidated balance sheets.
Costs and estimated profits on uncompleted contracts and related amounts billed were as follows (in thousands):
| September 30, 2025 | December 31, 2024 | |
|---|---|---|
| Costs incurred on uncompleted contracts | $148,600 | $122,951 |
| Estimated profits, thereon | 70,927 | 58,373 |
| Total costs and estimated profits on uncompleted contracts | 219,527 | 181,324 |
| Less: billings to date | 178,891 | 143,251 |
| Net | $40,636 | $38,073 |
Such amounts were included in the accompanying unaudited condensed consolidated balance sheets for September 30, 2025 and December 31, 2024 under the following captions (in thousands):
| September 30, 2025 | December 31, 2024 | |
|---|---|---|
| Costs and estimated profits in excess of billings | $57,696 | $50,735 |
| Billings in excess of costs and estimated profits | (17,060) | (12,662) |
| Net | $40,636 | $38,073 |
During the nine months ended September 30, 2025 and 2024, $7.9 million and $5.3 million of the balances that were previously classified as contract liabilities at the beginning of the period were recognized in revenues, respectively. Contract asset and liability changes were primarily due to normal activity and timing differences between our performance and customer payments.
NOTE 7 –INCOME TAXES
The following table presents provision for income taxes (in thousands, except for effective tax rate):
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Income before provision for income taxes | $29,452 | $23,732 | $88,221 | $62,291 |
| Provision for income taxes | 7,821 | 2,631 | 22,389 | 13,165 |
| Effective tax rate | 26.6% | 11.1% | 25.4% | 21.1% |
We are subject to income taxes in the U.S. and foreign jurisdictions. Significant judgment is required in determining our provision for income taxes and evaluating our uncertain tax positions. The effective tax rate increased primarily due to a lower tax benefit from research and development tax credits, lower tax benefit from stock compensation vested during the period, partially offset by a higher benefit for state income taxes.
While we believe that we have adequately provided for all uncertain tax positions, or tax positions where we believe it is not more-likely-than-not that the position will be sustained upon review, amounts asserted by tax authorities could be greater or less than our accrued position. Accordingly, our provisions on federal, state and foreign tax related matters to be recorded in the future may change as revised estimates are made or the underlying matters are settled or otherwise resolved with the respective tax authorities.
On July 4, 2025, the United States Congress passed the budget reconciliation bill H.R. 1, known as the One Big Beautiful Bill Act (“OBBBA”). Key provisions include the repeal of Section 174 R&D capitalization requirements, the extension of 100% bonus depreciation, restoration of the Section 163(j) interest limitation to an EBITDA basis, and the introduction of a 1% charitable contribution deduction floor. As of September 30, 2025, the immediate expensing of R&D costs under Section 174, the continuation of 100% bonus depreciation, and the restoration of the EBITDA-based Section 163(j) limitation are expected to decrease cash taxes in the short term and generate a federal net operating loss. These changes are not expected to have a material impact on the Company’s effective tax rate.
The Organization of Economic Cooperation and Development (“OECD”) continues to release additional guidance, including administrative guidance on how Pillar Two rules should be interpreted and applied by jurisdictions as they adopt Pillar Two. A number of countries have utilized the administrative guidance as a starting point for legislation that went into effect January 1, 2024. As of September 30, 2025, DXP anticipates the impact of Pillar Two to be immaterial to the Company based on current legislation that has been enacted to date.
NOTE 8 –LONG-TERM DEBT
Long-term debt consisted of the following (in thousands):
| September 30, 2025 | December 31, 2024 | |
|---|---|---|
| ABL Revolver | $— | $— |
| Amended Senior Secured Term Loan B due October 13, 2030(1) | 643,005 | 647,876 |
| Promissory Note due November 1, 2029 | 1,000 | 1,000 |
| Total debt | 644,005 | 648,876 |
| Less: current maturities | (6,595) | (6,595) |
| Total long-term debt | $637,410 | $642,281 |
| Unamortized discount and debt issuance costs | 18,014 | 20,597 |
| Long-term debt, net of unamortized discount and debt issuance costs | $619,396 | $621,684 |
| (1) The fair value of the Amended Term Loan B due October 13, 2030 using level 2 input values was $647.8 million and $657.6 million as of September 30, 2025 and December 31, 2024, respectively. | ||
Senior Secured Term Loan B:
On October 3, 2024, the Company entered into an amendment on its existing Senior Secured Term Loan B (the “Term Loan Amendment”), which provides for, among other things, an additional $105.0 million in new incremental commitments. The Term Loan Amendment refinanced the existing Senior Term Loan B and replaced it with an Amended Senior Secured Term Loan B with total borrowings of $649.5 million. The Senior Secured Term Loan B amortizes in equal quarterly installments of 0.25 percent, with the remaining balance being payable on October 13, 2030, when the facility matures.
As of September 30, 2025 there was $643.0 million outstanding under the Amended Senior Secured Term Loan B.
Interest rate
The interest rate for the Amended Senior Secured Term Loan B was 7.91 percent and 8.32 percent as of September 30, 2025 and December 31, 2024, respectively.
Facility Size Increases
The Senior Secured Term Loan B allows for incremental increases in facility size up to an aggregate of $100 million.
Prepayments
We are required to repay the Senior Secured Term Loan B with the proceeds from certain asset sales, certain debt issuances, and certain insurance proceeds. In addition, on an annual basis, we are required to repay an amount equal to 50 percent of excess cash flow, as defined in the Senior Secured Term Loan B, reducing to 25 percent if our Total Leverage Ratio is less than or equal to 3.00 to 1.00. No payment of excess cash flow is required if the Total Leverage Ratio is less than or equal to 2.50 to 1.00.
Restrictive Covenants
The Company’s primary financial covenant under the Term Loan B is a Secured Leverage Ratio. The Term Loan B Agreement requires that the Company’s Secured Leverage Ratio as of September 30, 2025 to be less than 5.50 to 1.00.
As of September 30, 2025, the Company’s Secured Leverage Ratio was 2.31 to 1.00.
ABL Revolver:
On July 1, 2025, the Company entered into an Increase Agreement (the “Increase Agreement”) to which the aggregate commitments under the Company's existing asset-based revolving credit facility (the "ABL Facility") were increased by $50 million. Following the effectiveness of the Increase Agreement, the total commitments under the ABL Facility increased from $135.0 million to $185.0 million.
On July 19, 2022, the Company entered into an Amended and Restated Loan and Security Agreement (the “ABL Credit Agreement”) that provided for a $135.0 million asset-backed revolving line of credit (the "ABL Revolver"). Subject to the conditions set forth in the ABL Credit Agreement, the ABL Revolver may be increased in increments of $10.0 million up to an aggregate of $50.0 million. The ABL Revolver matures on July 19, 2027. Interest accrues on outstanding borrowings at a rate equal to SOFR plus a margin ranging from 1.25 percent to 1.75 percent per annum, or at an alternate base rate, Canadian prime rate or Canadian base rate plus a margin ranging from 0.25 percent to 0.75 percent per annum, in each case, based upon the average daily excess availability under the ABL Revolver for the most recently completed calendar quarter. Fees payable on the unused portion of the facility range from 0.25 percent to 0.375 percent per annum. At September 30, 2025 the unused line fee was 0.375 percent and there wereno amounts outstanding under the ABL Revolver.
Guarantees
Each of our current and future wholly owned material U.S. subsidiaries and DXP Enterprises, Inc. guarantees the obligations of our borrower under the ABL Revolver. Additionally, each of our Canadian subsidiaries guarantees the obligations of our Canadian borrower subsidiaries under the ABL Revolver.
Security
Obligations under the U.S. Borrowing Base are primarily secured, subject to certain exceptions, by a first-priority secure interest in the accounts receivable, inventory and related assets of our wholly owned, material U.S. subsidiaries. The security interest in accounts receivable, inventory, and related assets of the U.S. borrower subsidiaries ranks prior to the security interest in this collateral which secures the Term Loan B. The obligations under the Canadian Borrowing Base are primarily secured, subject to certain exceptions, by a first-priority secure interest in the accounts receivable, inventory and related assets of our wholly owned, material Canadian subsidiaries and our wholly owned material U.S. subsidiaries.
Excess Availability
The borrowing availability under our credit facility was $153.4 million and $125.6 million at September 30, 2025 and December 31, 2024, respectively.
Interest rate
The interest rate for the ABL Revolver was 7.50 percent and 7.75 percent as of September 30, 2025 and December 31, 2024, respectively.
Facility Size Increases
Effective, July 1, 2025, the Company exercised its right to increase the ABL Credit Agreement by an aggregate amount of $50 million.
Financial Covenant
The Company's principal financial covenant under the ABL Credit Agreement include a Fixed Charge Coverage Ratio. The Fixed Charge Coverage Ratio under the ABL Credit Agreement is defined as the ratio for the most recently completed four-fiscal quarter period, of (a) EBITDA minus capital expenditures (excluding those financed or funded with debt (other than the ABL Loans), (ii) the portion thereof funded with the net proceeds from asset dispositions of equipment or real property which the Company is permitted to reinvest pursuant to the Term Loan and the portion thereof funded with the net proceeds of casualty insurance or condemnation awards in respect of any equipment and real estate which DXP is not required to use to prepay the ABL Loans pursuant to the Term Loan B Agreement or with the proceeds of casualty insurance or condemnation awards in respect of any other property) minus cash taxes paid (net of cash tax refunds received during such period), to (b) fixed charges. The Company is restricted from allowing its fixed charge coverage ratio to be less than 1.00 to 1.00 during a compliance period, which is triggered when the availability under the ABL Revolver falls below a threshold set forth in the ABL Credit Agreement. As of September 30, 2025, the Company's Fixed Charge Coverage Ratio was 2.18 to 1.00.
The Company was in compliance with all financial covenants as of September 30, 2025.
As of September 30, 2025, the maturities of long-term debt for the next five years and thereafter were as follows (in thousands):
| Amount | |
|---|---|
| 2025 | $1,724 |
| 2026 | 6,595 |
| 2027 | 6,595 |
| 2028 | 6,595 |
| 2029 | 7,095 |
| Thereafter | 615,401 |
| Total | $644,005 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.